secwatch.observer — SEC 8-K summary
======================================

Issuer:     Health In Tech, Inc. (HIT)
CIK:        0002019505
Form:       8-K
Filed at:   2026-10-16T20:30:14+00:00
Accession:  0001213900-26-110269
Event type: regulatory
Sentiment:  negative
Materiality: 0.62
Item codes: 3.01
LLM model:  deepseek-v4.1-flash:cloud@v2

Health In Tech gets two Nasdaq deficiency letters: audit committee makeup and sub-$1 bid price
--------------------------------------------------------------------------------

- Oct 14, 2026 Nasdaq letter: Board is 2-of-4 independent and Audit Committee has only 2 members after Sanjay Shrestha resigned Aug 10, 2026.
- Breaches Nasdaq Rules 5605(b)(1) and 5605(c)(2)(A); cure period runs to the earlier of the next annual meeting or Aug 10, 2027.
- Annual meeting set for Nov 10, 2026, where Health In Tech expects to elect a new independent director and add them to the Audit Committee.
- Oct 12, 2026 letter: Class A stock (HIT) closed below $1.00 for 30 straight business days, violating Rule 5550(a)(2); 180-day cure ends April 12, 2027.
- Regaining the bid price requires 10 consecutive closes at $1.00+; company may use a reverse stock split, and a second 180-day period is possible.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/2019505/000121390026110269/0001213900-26-110269-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/2019505/000121390026110269/ea0308864-8k_health.htm
  HTML page:      https://secwatch.observer/filing/0001213900-26-110269

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer